CSL reports new anti-corruption policy, lower emissions

Biopharmaceutical company CSL adopted a new anti-bribery and anti-corruption policy, lowered lost time injury frequency rates (LTIFR) by 30% and lowered energy consumption, greenhouse gas and waste intensity per unit of vaccine and plasma production, against a backdrop of net profit after tax of AU$941m.

Upgrade your subscription to access this article

Subscribe to gain unlimited access to news, research and analysis of ESG factors for ASX listed companies and investors.
Become a premium subscriber today.
Already A Subscriber?

Read more: CSLwateranti-corruptionenergyanti-briberybiopharmaceuticalwastecorporate responsibilityemployee lost time injury frequency ratesEnvironmentlitffsustainability report